53 results
PRE 14A
EQ
Equillium Inc
31 Mar 23
Preliminary proxy
4:02pm
and Mr. Steel are not considered independent because of their current employment with us.
BOARD LEADERSHIP STRUCTURE
Our Board is currently chaired … Lilly and as Executive Director of Investor Relations. Before joining Amylin, Ms. Zedelmayer held various leadership positions within project
8-K
EX-99.1
n5c4te9 8hq9lc
23 Dec 22
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement
4:11pm
425
tfqka5st
6 Dec 22
Business combination disclosure
7:02am
8-K
EX-99.2
t6duay wnbnildbc0dl6
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
EX-99.1
c300k4o4nyh
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
1t7ln1n3
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
425
8e9458305 jeec5dleyb
14 Nov 22
Business combination disclosure
4:20pm
8-K
EX-99.1
3501p8k8 r9v
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
n15za
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
ohbrj9
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
2kwrezj
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
mke9dmdkvc2b8 3mgp
27 Sep 22
Business combination disclosure
9:30am
8-K
EX-99.1
2ptvz
27 Sep 22
Other Events
9:28am
8-K
sxkyan
27 Sep 22
Other Events
9:28am
425
xegmcxd3q nj8y
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-99.1
jbsad4t
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm